MRRS adds "Partnerships, Licensing, Investments and M&A Deals and Trends for March 2016 in Pharmaceuticals" latest studies, published in Nov 2016.

Scope
– Analysis of the market trends for the pharmaceutical industry in the global arena.
– Review of deal trends in the cardiovascular, central nervous system, dermatology, ear nose throat disorders, gastrointestinal, genito urinary system and sex hormones, hematological disorders, hormonal disorders, immunology, infectious disease, male health, metabolic disorders, mouth and dental disorders, musculoskeletal, oncology, ophthalmology, respiratory, toxicology, and women’s health segments.
– Analysis of partnerships, licensing, M&As, equity/debt offerings, private equity, and venture financing deals in the pharmaceutical industry.
– Analysis of therapy areas which are very active in terms of venture capital financing, partnerships, licensing agreements, equity/debt offerings, and M&As.
– Analysis of deals based on different payment modes, including upfront and milestone payments, primarily in partnerships and licensing agreements in the pharmaceutical industry.
– Analysis of partnership and licensing deals based on clinical stage of development of products.
– Summary of the pharmaceutical deals globally in the six months.
– Information on the top deals happened in the pharmaceutical industry.
– Geographies covered include – North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa.
– League tables of financial advisors in M&As and equity/debt offerings. This includes key advisors such as Morgan Stanley, Credit Suisse, and Goldman Sachs.

Table of Contents
1 Table of Contents 2
2 Pharmaceuticals & Healthcare, Global, Deal Summary 12
2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, March 2016 12
2.2 Pharmaceuticals & Healthcare, Global, Major Deals, March 2016 14
2.2.1 Sanofi Prices Public Offering of Notes For USD2 Billion 14
2.2.2 Perrigo Raises USD1.2 Billion in Public Offering of Notes 14
2.2.3 Shanghai Shyndec Pharma to Acquire Stakes in 12 Pharma Companies for USD1.2 Billion 15
2.2.4 AmerisourceBergen Raises USD1.17 Billion in Private Placement of Shares up on Exercise of Warrants 15
2.2.5 Royalty Pharma Acquires Royalty Rights of Xtandi from University of California, Los Angeles for USD1.14 Billion 15
2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, March 2016 17
2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, March 2016 18
3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type 19
3.1 Pharmaceuticals & Healthcare, Global, M&A, March 2016 19
3.1.1 Top M&A Deals in March 2016 20
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, October 2015 - March 2016 21
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, March 2016 22
3.2.1 Top Equity Offering Deals in March 2016 23
3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, October 2015 - March 2016 24
3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, March 2016 3.3.1 Top PE/VC Deals in March 2016 26
3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, March 2016 27
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, March 2016 28
3.3.4 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, October 2015-March 2016 30
3.3.5 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, October 2015-March 2016 31
4 Pharmaceuticals & Healthcare, Global, Partnership Deals, March 2016 32
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, March 2016 32...

List of Tables and Figures
Table 1: Pharmaceuticals & Healthcare, Global, Deals Summary, Number of Deals and Deal Values (US$ m), October 2015 - March 2016 13
Table 2: Pharmaceuticals & Healthcare, Global, Major Deals, March 2016 14
Table 3: Pharmaceuticals & Healthcare, Global, Number Of Deals and Deal Values (%), March 2016 18
Table 4: Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), October 2015 - March 2016 20
Table 5: Pharmaceuticals & Healthcare, Global, Top M&A Deals, March 2016 20
Table 6: Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), by Therapy Area, October 2015 - March 2016 21
Table 7: Pharmaceuticals & Healthcare, Global, Equity Offerings, Deals Summary, Number of Deals and Deal Values (US$ m), October 2015 - March 2016 23
Table 8: Pharmaceuticals & Healthcare, Global, Top Equity Offering Deals, March 2016 23
Table 9: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Deals Summary, Number of Deals and Deal Values (US$ m), October 2015 - March 2016 24
Table 10: Pharmaceuticals & Healthcare, Global, PE/VC, Deals Summary, Number of Deals and Deal Values (US$ m), October 2015 - March 2016 26
...

Browse Complete Report with TOC @
http://www.marketresearchreportstore.com/shop/partnerships-licensing-investments-and-ma-deals-and-trends-for-march-2016-in-pharmaceuticals

Ask a sample or any futher questions, please feel free to contact us:
Tel: +00-1-626-3463946 - U.S
Email: [email protected]
Web: http://www.marketresearchreportstore.com/